$166 Million is the total value of Michael & Susan Dell Foundation's 5 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VEA | Buy | VANGUARD TAX-MANAGED INTL FDftse dev mkt etf | $112,532,000 | -2.9% | 2,342,944 | +3.3% | 67.81% | -18.9% |
| New | GITLAB INC | $26,980,000 | – | 495,507 | +100.0% | 16.26% | – | |
| MPLN | MULTIPLAN CORPORATION | $23,634,000 | +5.6% | 5,050,000 | 0.0% | 14.24% | -11.8% | |
| COIN | New | COINBASE GLOBAL INC | $2,544,000 | – | 13,399 | +100.0% | 1.53% | – |
| MPLNWS | MULTIPLAN CORPORATION*w exp 02/13/202 | $258,000 | -19.1% | 250,000 | 0.0% | 0.16% | -32.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JPMORGAN CHASE & CO | 23 | Q3 2019 | 57.9% |
| AETNA INC NEW | 20 | Q3 2018 | 28.3% |
| INTREXON CORP | 18 | Q2 2018 | 14.6% |
| VANGUARD TAX-MANAGED INTL FD | 15 | Q3 2023 | 100.0% |
| BERKSHIRE HATHAWAY INC DEL | 14 | Q3 2019 | 13.8% |
| ZIOPHARM ONCOLOGY INC | 13 | Q2 2018 | 0.6% |
| CROWN CASTLE INTL CORP NEW | 12 | Q3 2017 | 43.9% |
| MULTIPLAN CORPORATION | 12 | Q3 2023 | 0.3% |
| MULTIPLAN CORPORATION | 8 | Q3 2022 | 26.3% |
| TIME WARNER INC | 8 | Q3 2015 | 17.6% |
View Michael & Susan Dell Foundation's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-04-08 |
| 144 | 2024-03-21 |
| 13F-HR | 2024-02-14 |
| 144 | 2023-12-27 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Michael & Susan Dell Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.